Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/27/2011WO2011081915A3 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
10/27/2011WO2011075799A3 Oral antidepressant formulation
10/27/2011WO2011069045A3 Synthesis of syrbactin proteasome inhibitors
10/27/2011WO2011069032A3 Formulations, salts and polymorphs of transnorsertraline and uses thereof
10/27/2011WO2011066182A3 Socs3 inhibition promotes cns neuron regeneration
10/27/2011WO2011065800A3 Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same
10/27/2011WO2011060295A8 Kinase inhibitors
10/27/2011WO2011059207A3 Arylpiperazine-containing purine derivatives and uses thereof
10/27/2011WO2011056985A3 Substituted heterocyclic compounds
10/27/2011WO2011056773A3 Inhibiting neurotransmitter reuptake
10/27/2011WO2011056653A3 Clonidine formulations having antimicrobial properties
10/27/2011WO2011056511A3 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
10/27/2011WO2011053861A8 Kinase inhibitors
10/27/2011WO2011047439A8 Novel parasite therapy
10/27/2011WO2011047350A3 Emesis treatment
10/27/2011WO2011047319A8 Antimicrobial compounds and methods of making and using the same
10/27/2011WO2011038205A3 Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh
10/27/2011WO2011004282A4 Novel polymorphic form of teriflunomide salts
10/27/2011WO2010143971A3 Lipophilic drug carrier
10/27/2011WO2010121600A3 Particulate pharmaceutical composition having an opioid and an opioid antagonist
10/27/2011WO2010119365A3 A medicinal cream made using clotrimazole and chitosan and a process to make the same
10/27/2011WO2010078421A8 Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
10/27/2011WO2002023190A8 Methods and products related to low molecular weight heparin
10/27/2011US20110265198 Genome editing of a Rosa locus using nucleases
10/27/2011US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
10/27/2011US20110264043 Method of loading a drug library into an infusion pump
10/27/2011US20110264026 Azo Derivatives and Uses Thereof in Phototherapy
10/27/2011US20110263920 Advanced methods and systems for treating cell proliferation disorders
10/27/2011US20110263721 Aryl di-substituted propenone compounds
10/27/2011US20110263720 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
10/27/2011US20110263719 Polymorphic form of rasagiline mesylate
10/27/2011US20110263718 Process for the preparation of o-desmethylvenlafaxine
10/27/2011US20110263716 Colchine compositions and methods
10/27/2011US20110263715 Local Anesthetic Emulsion Compositions and Methods of Making and Using the Same
10/27/2011US20110263714 Reverse Vesicle
10/27/2011US20110263713 Polymorphs
10/27/2011US20110263712 Process for the preparation of vorinostat
10/27/2011US20110263711 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
10/27/2011US20110263710 Transepithelial methods of using gamma aminobutyric acid compositions for pain relief
10/27/2011US20110263709 Method for obtaining polyunsaturated fatty acid-containing compositions from microbial biomass
10/27/2011US20110263708 Over-production of dihomo linolenic acid by a mutant strain of parietochloris incisa
10/27/2011US20110263706 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester
10/27/2011US20110263705 Transdermal delivery of ketoprofen polar derivates
10/27/2011US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011US20110263703 Solid forms of selective androgen receptor modulators
10/27/2011US20110263702 Methods and Compositions for Improved Chromium Complexes
10/27/2011US20110263701 Gabapentin enacarbil compositions
10/27/2011US20110263700 Antrocin containing pharmaceutical compositions for inhibiting cancer cells
10/27/2011US20110263699 1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence
10/27/2011US20110263698 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
10/27/2011US20110263697 Methods of Reducing Oxidative Modification of a Muscle Cell Protein
10/27/2011US20110263696 Proanthocyanidins from cinnamon and its water soluble extract inhibit tau aggregation
10/27/2011US20110263695 NFAT Signal Inhibitor and Hair-Growing Agent
10/27/2011US20110263694 Use of Xanthone Derivatives as a Medicament for Cancer
10/27/2011US20110263693 Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
10/27/2011US20110263692 Therapeutic compounds
10/27/2011US20110263691 Methods concerning ppar delta and antagonists thereof
10/27/2011US20110263688 Coferons and methods of making and using them
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263686 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/27/2011US20110263685 Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263683 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
10/27/2011US20110263682 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53
10/27/2011US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011US20110263680 Reduced size self-delivering rnai compounds
10/27/2011US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis
10/27/2011US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011US20110263677 Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110263676 Small interfering rna for gene knockdown of the subcutaneous n-methyl-d-aspartate receptor nr1 subunit, and it's application on pharmaceutics
10/27/2011US20110263675 Methods of modulating mesenchymal stem cell differentiation
10/27/2011US20110263674 C-nitroso-derived nitroxyl donors
10/27/2011US20110263673 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives
10/27/2011US20110263672 Metabolites of Wortmannin Analogs and Methods of Using the Same
10/27/2011US20110263671 Novel salts of sunitinib
10/27/2011US20110263670 Novel polymorphs of sunitinib and processes for their preparation
10/27/2011US20110263669 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors
10/27/2011US20110263668 Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure
10/27/2011US20110263667 Salts of isobutyric acid (1 r*,2r*,4r*) -2- (2- - ethyl)-5-phenyl-bicyclo [2.2.2] oct-5-en-2-yl
10/27/2011US20110263666 process for the preparation or purification of olmesartan medoxomil
10/27/2011US20110263665 Formulations comprising an anti-microbial composition
10/27/2011US20110263664 Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
10/27/2011US20110263663 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/27/2011US20110263662 1,2-diamido-ethylene derivatives as orexin antagonists
10/27/2011US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011US20110263660 Antihypertensive pharmaceutical composition
10/27/2011US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011US20110263658 Renin inhibitors
10/27/2011US20110263657 Diaryl ureas for treating heart failure
10/27/2011US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011US20110263654 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/27/2011US20110263653 Migrastatin analog compositions and uses thereof
10/27/2011US20110263652 Treatment and/or Prevention of Inner Ear Conditions by Modulation of a Metabotropic Glutamate Receptor
10/27/2011US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263650 Tubulysin D Analogues
10/27/2011US20110263649 Crystalline form of lenalidomide and a process for its preparation
10/27/2011US20110263648 Bridged tetrahydronaphthalene derivatives
10/27/2011US20110263647 Fluoroisoquinoline substituted thiazole compounds and methods of use
10/27/2011US20110263646 Pharmaceutical topical compositions
10/27/2011US20110263645 Compositions and Methods of Treating Retinal Disease
1 ... 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 ... 7860